HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Developmental alterations of alpha-fetoprotein sugar chain in amniotic fluids analyzed by lectin affinity electrophoresis.

Abstract
Affinity electrophoresis of human alpha-fetoprotein (AFP) in amniotic fluid from pregnant women between 6 to 42 weeks of gestation and in the serum of a yolk sac tumor was performed with concanavalin A (Con A), lentil lectin (LCA), erythroagglutinating phytohemagglutinin (E-PHA) and Allomyrina dichotoma lectin (allo A). Separated AFP bands were detected by sensitive antibody-affinity blotting. In the first trimester, amniotic fluid AFP showed elevated percentages of Con A-nonreacting AFP (AFP-C1) and LCA weakly-reacting AFP (AFP-L2) as previously reported. Additionally, high percentages of E-PHA strongly-reacting AFP (AFP-P5) and E-PHA-reacting AFP (AFP-P4) were observed. E-PHA-nonreacting AFP (AFP-P1), E-PHA weakly-reacting AFP (AFP-P3f), allo A-nonreacting AFP (AFP-A1) and asialo-AFP, AFP-A1 s, were present only in amniotic fluids from 6 to 17 weeks of gestation. With advancing gestation, percentages of AFP-C1, AFP-P4 and AFP-P5 decreased and AFP-L2, AFP-P3f, AFP-A1, and AFP-A1 s disappeared by the end of 18 weeks. The glycoforms of serum AFP of the yolk sac tumor resembled those of amniotic fluid AFP in the early gestational stages.
AuthorsM Ohta, N Kawahara, M Liu, K Taketa, T Kudo, H Taga
JournalActa medica Okayama (Acta Med Okayama) Vol. 52 Issue 1 Pg. 27-33 (Feb 1998) ISSN: 0386-300X [Print] Japan
PMID9548991 (Publication Type: Journal Article)
Chemical References
  • Lectins
  • alpha-Fetoproteins
  • Concanavalin A
Topics
  • Amniotic Fluid (chemistry, metabolism)
  • Carbohydrate Conformation
  • Carbohydrate Sequence
  • Concanavalin A
  • Electrophoresis, Agar Gel
  • Endodermal Sinus Tumor (chemistry)
  • Gestational Age
  • Humans
  • Immunoblotting
  • Immunoenzyme Techniques
  • Lectins (metabolism)
  • Molecular Sequence Data
  • alpha-Fetoproteins (immunology, metabolism)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: